Safety of atazanavir/ritonavir with tenofovir disoproxil fumarate in HIV-infected adolescents

被引：0
|
作者：
Bunupuradah, T. [2 ]
Techasaensiri, C. [1 ]
Keadpudsa, S. [2 ]
Srimuan, A. [2 ]
Sahakijpicharn, T. [1 ]
Sriheara, C. [2 ]
Thammajaruk, N. [2 ]
Prasitsuebsai, W. [2 ]
Ananworanich, J. [3 ,4 ]
Puthanakit, T. [2 ,5 ]
机构：
[1] Mahidol Univ, Ramathibodi Hosp, Bangkok 10700, Thailand
[2] Thai Red Cross AIDS Res Ctr, HIV Netherlands Australia Thailand Res Collaborat, Bangkok, Thailand
[3] Chulalongkorn Univ, HIV Netherlands Australia Thailand Res Collaborat, Thai Red Cross AIDS Res Ctr, SEARCH, Bangkok, Thailand
[4] Chulalongkorn Univ, Fac Med, Dept Internal Med, Bangkok 10330, Thailand
[5] Chulalongkorn Univ, Bangkok, Thailand
来源：
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES | 2014年 / 21卷
关键词：
D O I：
10.1016/j.ijid.2014.03.1034
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
55.008
引用
收藏
页码：296 / +
页数：2
相关论文
共 50 条
  • [41] Administration of tenofovir disoproxil fumarate-based antiretroviral therapy in an HIV-infected patient following unilateral nephrectomy
    Biagi, Mark
    Badowski, Melissa
    Chiampas, Thomas
    Young, Jeremy
    Vaughn, Pyrai
    Shicker, Louis
    Patel, Mahesh
    [J]. INTERNATIONAL JOURNAL OF STD & AIDS, 2016, 27 (09) : 808 - 811
  • [42] Tenofovir disoproxil fumarate-associated hypophosphatemia as determined by fractional excretion of filtered phosphate in HIV-infected patients
    Cheng, Chien-Yu
    Chang, Shu-Yin
    Lin, Mei-Hui
    Ku, Shin-Yen
    Sun, Na-Lee
    Cheng, Shu-Hsing
    [J]. JOURNAL OF INFECTION AND CHEMOTHERAPY, 2016, 22 (11) : 744 - 747
  • [43] Decreased bone density (BMD) in HIV-infected children treated with tenofovir disoproxil fumarate (TDF)-containing HAART
    Gafni, RI
    Hazra, R
    Reynolds, JC
    Maldarelli, F
    Tullio, A
    DeCarlo, E
    Worrell, C
    Zuckerman, J
    Zeichner, S
    [J]. PEDIATRIC RESEARCH, 2004, 55 (04) : 329A - 329A
  • [44] Bone mass changes in HIV-infected individuals after a 48-week treatment with tenofovir disoproxil fumarate
    Tsekes, G
    Tsogas, N
    Chini, M
    Lioni, A
    Mangafas, N
    Grammelis, V
    Papagiannakopoulos, I
    Lazanas, MC
    [J]. ANTIVIRAL THERAPY, 2005, 10 (08) : L53 - L54
  • [45] Treatment with tenofovir alafenamide fumarate worsens the lipid profile of HIV-infected patients versus treatment with tenofovir disoproxil fumarate, each coformulated with elvitegravir, cobicistat, and emtricitabine
    Cid-Silva, Purificacion
    Fernandez-Bargiela, Noelia
    Margusino-Framinan, Luis
    Balboa-Barreiro, Vanesa
    Mena-De-Cea, Alvaro
    Lopez-Calvo, Soledad
    Vazquez-Rodriguez, Pilar
    Martin-Herranz, Isabel
    Miguez-Rey, Enrique
    Poveda, Eva
    Castro-Iglesias, Angeles
    [J]. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2019, 124 (04) : 479 - 490
  • [46] Changes in Bone Mineral Density After Initiation of Antiretroviral Treatment With Tenofovir Disoproxil Fumarate/Emtricitabine Plus Atazanavir/Ritonavir, Darunavir/Ritonavir, or Raltegravir
    Brown, Todd T.
    Moser, Carlee
    Currier, Judith S.
    Ribaudo, Heather J.
    Rothenberg, Jennifer
    Kelesidis, Theodoros
    Yang, Otto
    Dube, Michael P.
    Murphy, Robert L.
    Stein, James H.
    McComsey, Grace A.
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2015, 212 (08): : 1241 - 1249
  • [47] Evolution of glomerular filtration rate in HIV-infected, HIV-HBV-coinfected and HBV-infected patients receiving tenofovir disoproxil fumarate
    Pradat, P.
    Le Pogam, M. -A.
    Okon, J. -B.
    Trolliet, P.
    Miailhes, P.
    Brochier, C.
    Maynard, M.
    Bailly, F.
    Zoulim, F.
    Cotte, L.
    [J]. JOURNAL OF VIRAL HEPATITIS, 2013, 20 (09) : 650 - 657
  • [48] Tenofovir disoproxil fumarate for the treatment of HIV infection
    Pham, Paul A.
    Gallant, Joel E.
    [J]. EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2006, 2 (03) : 459 - 469
  • [49] Long-Term (96-Week) Efficacy and Safety After Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in HIV-Infected, Virologically Suppressed Adults
    Raffi, Francois
    Orkin, Chloe
    Clarke, Amanda
    Slama, Laurence
    Gallant, Joel
    Daar, Eric
    Henry, Keith
    Santana-Bagur, Jorge
    Stein, David K.
    Bellos, Nicholaos
    Scarsella, Anthony
    Yan, Mingjin
    Abram, Michael E.
    Cheng, Andrew
    Rhee, Martin S.
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2017, 75 (02) : 226 - 231
  • [50] Nevirapine versus atazanavir/ritonavir, each combined with tenofovir disoproxil fumarate/emtricitabine, in antiretroviral-naive HIV-1 patients: the ARTEN Trial
    Soriano, Vicente
    Arasteh, Keikawus
    Migrone, Horacio
    Lutz, Thomas
    Opravil, Milos
    Andrade-Villanueva, Jaime
    Antunes, Francisco
    Di Perri, Giovanni
    Podzamczer, Daniel
    Taylor, Steve
    Domingo, Pere
    Gellermann, Holger
    de Rossi, Lothar
    [J]. ANTIVIRAL THERAPY, 2011, 16 (03) : 339 - 348
12345